Evidence map›Paper›PMID 42531075›Full record

ArticleNucleic acids research2026

Molecular basis of single-mismatch-induced nuclease-to-nickase conversion in TIGR-TasH.

Ruimin Zhou, Yancheng Zhan, Yangyue Sun, Runqin Wang, Tongyao Wang, Zhikun Liu, Zhengda Shan, Xuzichao Li, Shuqin Zhang, Nan Sun and 3 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ruimin ZhouTianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin's Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Yancheng ZhanTianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin's Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Yangyue SunTianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin's Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Runqin WangTianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin's Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Tongyao WangTianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin's Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Zhikun LiuTianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin's Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Zhengda ShanTianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin's Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Xuzichao LiTianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin's Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Shuqin ZhangTianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin's Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Nan SunTianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin's Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Heng ZhangTianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin's Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.ORCID 0000-0003-1112-7149
Zhiyong YuanTianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin's Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.ORCID 0000-0002-4745-6895
Jie YangTianjin Medical University Cancer Institute and Hospital, State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, National Clinical Research Center for Cancer, Tianjin Institute of Immunology, Tianjin's Clinical Research Center for Cancer, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.ORCID 0000-0003-4399-2532

Funding

Scientific Research Program of Tianjin Municipal Education Commission 2024ZD037Tianjin Key Medical Discipline TJYXZDXK-009ATianjin Key Medical Discipline TJYXZDXK-3-004B
6 · The paper itself

Abstract

Tandem interspaced guide RNA (TIGR)-Tas systems are a distinct class of RNA-guided double-stranded DNA nucleases that employ dual-spacer guide RNAs (tigRNAs) for PAM-independent target recognition. A single mismatch between the tigRNA and target DNA can convert Salicola phage CGphi29 (Sp)TasH from a double-strand nuclease into a nickase in a position-dependent manner, but the molecular basis underlying this functional switch remains unknown. Here, we combined biochemical analyses and cryo-electron microscopy to investigate tigRNA maturation and mismatched target recognition by the Nop domain of SpTasH. We show that the Nop domain is required for pre-tigRNA processing and stabilizes the mature tigRNA through extensive interactions, thereby establishing a cleavage-competent ribonucleoprotein complex. Structural analyses of SpTasH complexes bound to substrates containing single mismatches reveal that a mismatch at the 5'-most position of spacer A is readily accommodated through Nop domain-mediated stabilization of the spacer-target heteroduplex. In contrast, a mismatch proximal to the cleavage site destabilizes the heteroduplex, preventing recruitment of the corresponding HNH domain, thereby converting the complex into a nickase. Together, these findings establish the structural basis for position-dependent mismatch recognition and reveal how Nop domain-mediated tigRNA-target stabilization enables differential responses to mismatches, providing a foundation for engineering TIGR-Tas systems for genome-editing applications.

Indexed as

Base Pair MismatchDeoxyribonuclease IRNA, Guide, CRISPR-Cas SystemsCryoelectron MicroscopyModels, MolecularProtein DomainsDeoxyribonuclease IRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID42531075
PMCPMC13421893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.